Anal cancer and its screening using digital ano-rectal examination (DARE) in men living with HIV who have sex with men
has commissioned a subcommittee to look at the role of screening for
anal cancers in men living with HIV who have sex with men (MSM). The
group will initially focus on the merits and issues around routine
screening using DARE.
The issue in a nutshell:
incidence of anal cancer in men who have sex with men (MSM) living with
HIV is 50-100 times higher than the general population.
mainstay of curative treatment is to preserve the anal canal with
combined chemoradiotherapy (or with local excision surgery for small
cancer diagnosis and treatment can have significant effects on quality
of life and detecting cancer at an earlier stage can reduce morbidity
- Anal cancer survival outcomes are related to stage at presentation and hence early detection is a priority.
is now increasing evidence that incorporating regular digital
ano-rectal examination (DARE) into routine HIV care for those at highest
risk for anal cancer (i.e. MSM living with HIV) is acceptable to
patients and clinicians, and cost-effective in an Australian context.